3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
3
Unknown
1
Suspended
1
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
151
Leukemia
138
Leukemia, Myeloid, Acute
127
Myelodysplastic Syndromes
106
Precursor Cell Lymphoblastic Leukemia-Lymphoma
103
Lymphoma
87
Lymphoma, Non-Hodgkin
86
Multiple Myeloma
84
Hodgkin Disease
81
Lymphoma, Mantle-Cell
71
Lymphoma, Follicular
68
Lymphoma, Large B-Cell, Diffuse
60
Congenital Abnormalities
59
Myeloproliferative Disorders
58
Lymphoma, B-Cell, Marginal Zone
58
Leukemia, Myeloid, Chronic-Phase
56
Leukemia, Myelomonocytic, Chronic
52
Leukemia, Myeloid, Accelerated Phase
50
Burkitt Lymphoma
50
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
46
Lymphoma, Large-Cell, Immunoblastic
43
Anemia, Refractory, with Excess of Blasts
42
Waldenstrom Macroglobulinemia
41
Blast Crisis
40
Primary Myelofibrosis
38
Melanoma
35
Recurrence
34
Neoplasms, Plasma Cell
34
Dendritic Cell Sarcoma, Interdigitating
30
Lymphoma, T-Cell, Cutaneous
29
Interventions
Cisplatin
117
Oxaliplatin
111
Fluorouracil
100
Capecitabine
90
Docetaxel
69
Leucovorin
60
Irinotecan
57
Paclitaxel
49
S 1 (combination)
38
pembrolizumab
35
Trastuzumab
31
Radiotherapy
25
Bevacizumab
20
Nivolumab
19
Epirubicin
19
titanium silicide
18
Surgical Procedures, Operative
17
Carboplatin
17
Ramucirumab
16
Cetuximab
15
Gastrectomy
13
apatinib
12
Everolimus
12
Gemcitabine
11
Albumin-Bound Paclitaxel
10
Neoadjuvant Therapy
8
Folfox protocol
8
Drug Therapy
8
Chemotherapy, Adjuvant
8
Radiation
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Stomach Neoplasms
×
fludarabine phosphate
×
Clear all
NCT02876510
2025-02-04
ACTolog
Immatics US, Inc.
Phase 1
Completed
38 enrolled